Source link : https://www.newshealth.biz/health-news/sacubitril-valsartan-curbs-cardiotoxicity-from-chemotherapy/
CHICAGO — Sacubitril/valsartan (Entresto) was effective at keeping cardiotoxicity at bay in high-risk people receiving anthracycline chemotherapy in the SARAH trial. Cancer patients were less likely to have a greater than 15% reduction in global longitudinal strain (GLS) of the left ventricle if they had been randomly assigned the angiotensin receptor-neprilysin inhibitor (ARNI) treatment for […]
Author : News Health
Publish date : 2024-11-20 16:18:32
Copyright for syndicated content belongs to the linked Source.
Categories